Tanya Gupta, MD | UniHealth

Offices

4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

6 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gupta’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

6 of 6 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health Sutter Advantage +More (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
SCAN Balance (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Classic (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN MyChoice (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Strive (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
DualConnect (HMO D-SNP)	Santa Clara Family Health Plan	Listed	Sep 1, 2026

California Medical Board record

Licence A138407 · Current

Licensed to practise in California · since 2015 · expires 2027-01-31 · University of California, San Diego School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$645,620

Medicare paid this office $645,620 for 298 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Long return visit (40+ min)	64	$19,591	$157
Administration of chemotherapy into vein, 1 hour or less	39	$7,923	$141
New patient visit (60+ min)	36	$7,389	$205
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	25	$6,436	$106
Return visit (30+ min)	55	$5,418	$86

See all 18 services

Sort by

Every Original Medicare service billed

Long return visit (40+ min)	64	$19,591	$157
Administration of chemotherapy into vein, 1 hour or less	39	$7,923	$141
New patient visit (60+ min)	36	$7,389	$205
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	25	$6,436	$106
Return visit (30+ min)	55	$5,418	$86
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	40	$3,997	$68
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	11	$2,882	$78
Initial hospital care with moderate level of medical decision making at least 75 minutes	16	$2,463	$154
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	48	$1,512	$15
Return visit (30+ min)	14	$960	$64
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour	15	$674	$21
Injection of additional new drug or substance into vein	19	$630	$16
Injection of drug or substance into vein	14	$588	$39
Injection of drug or substance under skin or into muscle	20	$504	$14
Injection, zoledronic acid, 1 mg	12	$263	None
Injection, ondansetron hydrochloride, per 1 mg	13	$13	None
Injection, dexamethasone sodium phosphate, 1 mg	12	$12	None
Infusion, normal saline solution, 250 cc	15	$9	None

Who their Medicare patients are

298 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 12% · Women 67% · Also on Medicaid 12% · Health risk score 1.67. At or below the middle of the specialty; the typical hematology-oncology clinician is at 2.04.

Conditions among them: High blood pressure 63% · Cancer 53% · Chronic kidney disease 30% · Diabetes 28% · Coronary heart disease 24% · Depression 21% · Atrial fibrillation 19% · Heart failure 15% · COPD 11% · Dementia 9% · Stroke 7%.

The office billed $2,081,079, Medicare allowed $814,233 and paid $645,620; for 33,198 services of 96 kinds; $575,388 of it was for drugs given in the office and $70,232 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	298	33,198	75	1.67	$2,081,079	$645,620
2023	118	476	74	1.47	$168,731	$51,973
2022	134	496	74	1.73	$217,596	$55,892
2021	63	183	74	1.57	$67,956	$19,721
2018	53	160	71	3.88	$51,613	$13,705
2017	25	64	75	3.03	$19,960	$5,264

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	54	$22,142	$122
Long return visit (40+ min)	35	$11,730	$123
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	20	$5,266	$110
Return visit (30+ min)	25	$3,886	$84
New patient visit (60+ min)	11	$1,837	$167
Return visit (30+ min)	12	$1,536	$90

2022: 6 services

Sort by

Original Medicare services billed in 2022

Long return visit (40+ min)	49	$22,224	$123
Long return visit (40+ min)	28	$10,568	$124
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	42	$9,360	$93
Initial hospital care with moderate level of medical decision making at least 75 minutes	22	$4,299	$179
New patient visit (60+ min)	16	$2,673	$167
Return visit (30+ min)	16	$1,044	$65

2021: 4 services

Sort by

Original Medicare services billed in 2021

Long return visit (40+ min)	23	$5,788	$126
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	16	$3,495	$92
Return visit (30+ min)	21	$3,250	$90
Initial hospital care with moderate level of medical decision making at least 75 minutes	14	$2,515	$180

2018: 3 services

Sort by

Original Medicare services billed in 2018

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	32	$4,968	$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	24	$2,933	$122
Hospital discharge day management, 30 minutes or less	19	$1,337	$67

2017: 2 services

Sort by

Original Medicare services billed in 2017

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	15	$2,332	$65
Hospital discharge day management, 30 minutes or less	11	$729	$66

Medicaid work

$6,568 in 2023

Medicaid paid $6,568 for 130 billed services this clinician did in 2023, up to 17 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2023

Long return visit (40+ min)	130	$6,568

Sort by

Medicaid work by year

2023	130	1	17	$6,568
2022	143	2	17	$7,824
2018	47	2	18	$1,389

See the largest Medicaid services in earlier years

2022

Sort by

Largest Medicaid services in 2022

Long return visit (40+ min)	111	$6,978
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES	32	$846

2018

Sort by

Largest Medicaid services in 2018

SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	35	$785
1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES	12	$604

Drugs they prescribed that Part D paid

$349,149

Pharmacies billed $349,149 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

145 generic and 33 brand-name prescriptions · $349,149 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Exemestane	21	$4,266	$203
Anastrozole	31	$859	$28
Letrozole	33	$816	$25

Year by year

Sort by

Part D prescribing by year

2024	178	66	None	19%	$349,149
2023	227	56	None	None	$358,211
2022	229	55	None	None	$538,846
2021	103	35	None	None	$92,125
2020	35	17	None	None	$39,639
2019	61	23	None	23%	$147,195
2018	44	20	None	None	$1,687
2017	28	13	None	None	$2,717
2015	12	None	0% (0)	0%	$215

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 8 drugs

Sort by

Part D drugs prescribed in 2023

Verzenio	18	$266,589	$14,811
Exemestane	25	$9,907	$396
Anastrozole	53	$1,581	$30
Ondansetron	20	$962	$48
Letrozole	21	$624	$30
Tamoxifen Citrate	15	$438	$29
Prochlorperazine Maleate	12	$215	$18
Lorazepam	11	$38	$3

2022: 7 drugs

Sort by

Part D drugs prescribed in 2022

Verzenio	14	$200,202	$14,300
Exemestane	14	$4,754	$340
Anastrozole	59	$1,640	$28
Letrozole	22	$553	$25
Ondansetron	16	$305	$19
Prochlorperazine Maleate	11	$126	$11
Lorazepam	20	$80	$4

2021: 2 drugs

Sort by

Part D drugs prescribed in 2021

Anastrozole	32	$999	$31
Prochlorperazine Maleate	11	$198	$18

Money from drug and device companies

$2,152 in 2025

Sort by

Industry payments by year

2025	6	9	$1,860	$2,152
2024	6	21	$14,705	$16,579
2023	5	15	$4,718	$5,689
2022	2	17	$5,020	$7,304

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Merck Sharp & Dohme	None	$1,280	1 payment Consulting · 2025-07-09 · $1,280
Gilead Sciences	Trodelvy	$580	1 payment Consulting for Trodelvy · 2025-05-21 · $580
AstraZeneca Pharmaceuticals LP	Lynparza	$199	3 payments Meals · 2025-11-05 · $31 Meals for Enhertu · 2025-10-17 · $42 Meals for Lynparza · 2025-07-17 · $125
Kite Pharma	Yescarta	$57	2 payments Meals for Yescarta · 2025-12-02 · $30 Meals for Yescarta · 2025-05-23 · $27
E.R. Squibb & Sons L.L.C.	Opdivo	$20	1 payment Meals for Opdivo · 2025-03-25 · $20
Pfizer	Ibrance	$16	1 payment Education for Ibrance · 2025-04-28 · $16

See all 9 published payments

Sort by

Every published payment

Kite Pharma	Meals · 2025-12-02	Yescarta	$30
AstraZeneca Pharmaceuticals LP	Meals · 2025-11-05	None	$31
AstraZeneca Pharmaceuticals LP	Meals · 2025-10-17	Enhertu	$42
AstraZeneca Pharmaceuticals LP	Meals · 2025-07-17	Lynparza	$125
Merck Sharp & Dohme	Consulting · 2025-07-09	None	$1,280
Kite Pharma	Meals · 2025-05-23	Yescarta	$27
Gilead Sciences	Consulting · 2025-05-21	Trodelvy	$580
Pfizer	Education · 2025-04-28	Ibrance	$16
E.R. Squibb & Sons L.L.C.	Meals · 2025-03-25	Opdivo	$20

See earlier years (2024, 2023, 2022)

2024: $16,579

Sort by

Payments by company in 2024

Gilead Sciences	Trodelvy	$9,479	11 payments Consulting for Trodelvy · 2024-05-14 · $8,030 Meals for Trodelvy · 2024-05-14 · $39 Travel for Trodelvy · 2024-05-14 · $95 Meals for Trodelvy · 2024-05-04 · $22 Meals for Trodelvy · 2024-05-03 · $44 Meals for Trodelvy · 2024-05-03 · $44 Meals for Trodelvy · 2024-05-03 · $47 Meals for Trodelvy · 2024-05-03 · $91 Travel for Trodelvy · 2024-05-02 · $309 Travel for Trodelvy · 2024-05-02 · $328 Travel for Trodelvy · 2024-05-02 · $430
AstraZeneca Pharmaceuticals LP	Lynparza	$3,217	6 payments Consulting · 2024-11-19 · $1,110 Meals for Lynparza · 2024-10-24 · $6 Meals · 2024-10-11 · $38 Consulting · 2024-07-05 · $1,943 Meals · 2024-07-03 · $89 Meals · 2024-03-21 · $32
Novartis Pharmaceuticals	Kisqali	$2,363	1 payment Consulting for Kisqali · 2024-06-13 · $2,363
Pfizer	Ibrance	$1,260	1 payment Consulting for Ibrance · 2024-02-15 · $1,260
Endomagnetics	Magseed	$227	1 payment Meals for Magseed · 2024-11-26 · $227
Genentech	Kadcyla	$34	1 payment Meals for Kadcyla · 2024-01-18 · $34

2023: $5,689

Sort by

Payments by company in 2023

AstraZeneca Pharmaceuticals LP	Lynparza	$4,737	4 payments Consulting · 2023-12-12 · $1,110 Consulting · 2023-08-24 · $1,665 Consulting for Lynparza · 2023-05-23 · $1,943 Meals for Enhertu · 2023-04-24 · $19
Gilead Sciences	Trodelvy	$578	6 payments Meals for Trodelvy · 2023-12-05 · $111 Meals for Trodelvy · 2023-11-14 · $104 Meals · 2023-10-21 · $19 Meals for Trodelvy · 2023-08-25 · $110 Meals for Trodelvy · 2023-08-18 · $111 Meals for Trodelvy · 2023-02-24 · $124
Pfizer	Ibrance	$198	2 payments Meals for Ibrance · 2023-12-05 · $195 Meals for Comirnaty · 2023-06-26 · $3
AstraZeneca UK	Enhertu	$135	1 payment Meals for Enhertu · 2023-12-07 · $135
Abbvie	Botox	$41	2 payments Meals for Ubrelvy · 2023-07-26 · $15 Meals for Botox · 2023-04-27 · $26

2022: $7,304

Sort by

Payments by company in 2022

Gilead Sciences	Trodelvy	$7,282	16 payments Consulting for Trodelvy · 2022-12-09 · $5,020 Travel for Trodelvy · 2022-12-09 · $20 Travel for Trodelvy · 2022-12-09 · $42 Travel for Trodelvy · 2022-12-09 · $92 Meals for Trodelvy · 2022-12-09 · $8 Meals for Trodelvy · 2022-12-09 · $10 Meals for Trodelvy · 2022-12-09 · $19 Meals for Trodelvy · 2022-12-09 · $20 Meals for Trodelvy · 2022-12-09 · $38 Meals for Trodelvy · 2022-11-10 · $66 Travel for Trodelvy · 2022-11-04 · $385 Meals for Trodelvy · 2022-11-04 · $37 Meals for Trodelvy · 2022-11-04 · $37 Meals for Trodelvy · 2022-11-04 · $43 Travel for Trodelvy · 2022-11-03 · $279 Travel for Trodelvy · 2022-11-03 · $1,168
Abbvie	Botox	$22	1 payment Meals for Botox · 2022-09-02 · $22

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 76.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1154741031
Licence: CA A138407California A138407: Current · expires 2027-01-31
Trained: University of California, San Diego School of Medicine, 2014
Group: Sutter Bay Medical Foundation
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RH0003X (207RH0003X); Internal medicine (207R00000X); Federal specialty code 207RH0000X (207RH0000X); Medical oncology (207RX0202X)
Mailing address: 325 Distel Cir, Los Altos, CA, 94022
NPI first listed: 2014-04-18
NPI last updated: 2024-07-26
NPI record certified: 2024-07-26

This is when the NPI record was last certified, not a medical board exam.